患有的成年人的并发症和药物治疗负担
Katarzyna Bosak1, Kamil Wężyk2, Małgorzata Dec-Ćwiek3
1Jagiellonian University Medical College, Kraków, Poland.
Epilepsy & behavior : E&B
|September 28, 2025
概括
几乎一半的患有的成年人患有并发症,超过40%使用非抗发作药物 (ASM). 这些并发症和非ASM使用在焦点,耐药性和老年患者中更为常见.
科学领域:
- 神经学 神经学
- 临床药房 临床药房
- 流行病学 流行病学
背景情况:
- 影响了相当一部分成年人群.
- 伴随性疾病和多药在慢性疾病中很常见.
- 了解的这些因素对于全面的患者护理至关重要.
研究的目的:
- 为了确定患有的成年人并发症的患病率.
- 评估非抗发作药物 (ASM) 在这一群体中的使用情况.
- 为了确定与并发症和非ASM使用相关的因素.
主要方法:
- 前性,非干预性,单中心研究.
- 包括517名成年患者.
- 收集有关人口统计,类型,并发症 (ICD-10) 和非ASM药物 (ATC) 的数据.
主要成果:
- 48%的患者患有并发症,41%使用非ASM.
- 焦点性和耐药性与更高的并发病率和非ASM使用有关.
- 精神/行为,内分泌/代谢和循环疾病是最常见的.
- 选择性血清素再吸收抑制剂,抗精神病药物和甲状腺制剂是常见的非ASM.
- 73%的非ASM用户正在使用ASM,存在潜在的药物相互作用风险.
结论:
- 几乎一半的患有的成年人患有并发症,超过40%的人使用非ASM.
- 伴随性疾病和非ASM使用在焦点,耐药性和老年人中更为普遍.
- 对并发症和非ASM使用的系统评估对于优化管理和减轻药物相互作用至关重要.
相关概念视频
Epilepsy and Seizures: Overview
1.1K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
Drug Dosing: Geriatric Patients
199
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
199
Antiepileptic Drugs: Potassium Channel Activators
586
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
586
Antiepileptic Drugs: Glutamate Antagonists
851
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
851
Drug Dosing: Obese Patients
189
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
189
Antiepileptic Drugs: GABAergic Pathway Potentiators
1.1K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.1K


